Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery

Heart

Volumn 78, Issue 2, 1997, Pages 131-135

  Skinner, J S ^a   Farrer, M ^a   Albers, C J ^a   Piper, K ^b   Neil, H A W ^c   Adams, P C ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Angina; Coronary artery bypass graft surgery; Graft occlusion; Lp(a) lipoprotein; Mortality

Indexed keywords

LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANGINA PECTORIS; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT OCCLUSION; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL;

EID: 0030859416     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.2.131     Document Type: Article

References (28)

1. Berg K, Dahlen G, Frick MH. Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease. Clin Genet 1974;6:230-5.
2. Hoff HF, Beck GJ, Skibinski CI, Jurgens G, O'Neil J, Kramer J, et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988;77:1238-44.
3. Eritsland J, Arnesen H, Seljeflot I, Abdelnoor M, Gronseth K, Berg K, et al. Influence of lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting. Am J Cardiol 1994;74:1099-102.
4. Vlodaver Z, Edwards JE. Pathologic changes in aortic-coronary arterial saphenous vein grafts. Circulation 1971;44:719-28.
5. Lie JT, Lawrie GM, Morris GC. Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. Am J Cardiol 1977;40:906-14.
6. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:150-8.
7. Campeau L. Grading of angina pectoris [letter]. Circulation 1976;54:522-3.
8. Farrer M, Game FL, Albers CJ, Neil HA, Winocour PH, Laker MF, et al. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb 1994;14:1272-83.
9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
10. Campeau L, Lesperance J, Hermann J, Corbara F, Grondin CM, Bourassa MG. Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries. Circulation 1979;60(suppl I):I-1-5.
11. Campeau L, Enjalbert M, Lesperance J, Bourassa MG. Course of angina 1 to 12 years after aortocoronary bypass surgery related to changes in grafts and native coronary arteries. Can J Surg 1985;28:496-8.
12. de Feyter PJ, Serruys PW, Brower RW, van den Brand M, ten Katen HJ, Hugenholtz PG, et al. Comparison of preoperative, operative and postoperative variables in asymptomatic or minimally symptomatic patients to severely symptomatic patients three years after coronary artery bypass grafting: analysis of 423 patients. Am J Cardiol 1985;55:362-6.
13. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204.
14. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chew 1990;36:20-3.
15. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D. Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet 1988;i:1070-3.
16. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65.
17. Genest JJ, Jenner JL, McNamara JR, Ordovas JM, Silberman SR, Wilson PWF, et al. Prevalence of lipoprotein(a) [Lp(a)] excess in coronary artery disease. Am J Cardiol 1991;67:1039-45.
18. Tamura A, Watanabe T, Mikuriya Y, Nasu M. Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction. Br Heart J 1995;74:365-9.
19. Gushing GL, Gaubatz JW, Nava ML, Burdick BJ, Bocan TM, Guyton JR, et al. Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 1989;9:593-603.
20. FitzGibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary-bypass graft fate: long-term angiographic study. J Am Coll Cardiol 1991;17:1075-80.
21. Catinella FP, Cunningham JN, Srungaram RK, Baumann FG, Nathan IM, Glassman EA, et al. The factors influencing early patency of coronary artery bypass vein grafts: correlation of angiographic and ultrastructural findings. J Thorac Cardiovasc Surg 1982;83:686-700.
22. Cataldo G, Braga M, Pirotta N, Lavezzari M, Rovelli F, Marubini E. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA). Circulation 1993;88:93-8.
23. Solymoss BC, Marcil M, Wesolowska E, Lesperance J, Pelletier LC, Campeau L. Risk factors of venous aortocoronary bypass graft disease noted at late symptom-directed angiographic study. Can J Cardiol 1993;9:80-4.
24. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540-4.
25. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 1986;62:249-57.
26. Maher VMG, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA 1995;274:1771-4.
27. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation 1989;80:1313-19.
28. Haffner S, Orchard T, Stein E, Schmidt D, LaBelle P. Effect of simvastatin on Lp(a) concentrations. Clin Cardiol 1995;18:261-7.